Faculty Outstanding Research Output Awards



Efficacy and Safety of Nivolumab Plus Ipilimumab in Patients With Advanced Hepatocellular Carcinoma Previously Treated With Sorafenib - The CheckMate 040 Randomized Clinical Trial. JAMA Oncology, 2020-11-01, Vol.6 (11), p.e204564-e204564. HKU Authors: Thomas Yau.

Diverse effects of hepatic steatosis on fibrosis progression and functional cure in virologically quiescent chronic hepatitis B. Journal of Hepatology, 2020-10, Vol.73 (4), p.800-806. HKU Authors: LY Mak, Rex WH Hui, James Fung, Danny KH Wong, KS Cheung, MF Yuen, WK Seto.

Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial. The Lancet, 2020-05-30, Vol.395 (10238), p.1695-1704. HKU Authors: Ivan FN Hung, Simon Sin, Pauline Yeung, Ricky Ruiqi Zhang, Agnes YF Fung, Erica YW Yan, KH Leung, Jonathan Daniel Ip, Allen WH Chu, WM Chan, Anthony CK Ng, Jasper FW Chan, CS Lau, KH Chan, Kelvin KW To, KY Yuen.